U.S. pharma huge copyright scrapped two experimental weight loss products final 12 months—a as soon as-each day capsule, lotiglipron, due to elevated liver enzymes and also a twice-day-to-day capsule, danuglipron, as a result of potent Unwanted effects—but CEO Albert Bourla has repor